Eli Lilly stock tumbles after drug giant misses estimates and slashes profit guidance
Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase ...
Ozempic, Wegovy move closer to no longer being in shortage, FDA says
After years of ongoing shortages due to their growing popularity, all doses of both Ozempic and Wegovy are now listed as ...
Amgen’s Profit Beats Expectations on Lower Than Estimated Costs
Amgen Inc.’s third-quarter profit beat Wall Street estimates as the company’s expenses were lower than anticipated.
Semaglutide linked to reduced arthritis knee pain in people with obesity, study finds
People who lost a significant amount of weight with semaglutide saw major improvements in osteoarthritis knee pain, research published Wednesday in the New England Journal of Medicine finds.